Rho Announces New Business Segment


Applied Clinical Trials

Rho, a full-service CRO, announced a new Regulatory Strategy and Submissions business segment which will support their continued growth in helping sponsors plan, develop, and submit marketing applications. The new segment provides an integrated approach for regulatory, clinical, nonclinical, CMC, and statistical experts to work with clients.

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.